{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:35:17Z","timestamp":1790631317713,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2016YFC1000505"],"award-info":[{"award-number":["2016YFC1000505"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81120108010"],"award-info":[{"award-number":["81120108010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570954"],"award-info":[{"award-number":["81570954"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470727"],"award-info":[{"award-number":["81470727"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bone.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T18:17:34Z","timestamp":1528222654000},"page":"40-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["A bone-targeting drug-delivery system based on Semaphorin 3A gene therapy ameliorates bone loss in osteoporotic ovariectomized mice"],"prefix":"10.1016","volume":"114","author":[{"given":"K.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.F.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bone.2018.06.003_bb0005","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrendo.2015.71","article-title":"Short-term and long-term effects of osteoporosis therapies","volume":"11","author":"Reid","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.bone.2018.06.003_bb0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s001980050224","article-title":"Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis","volume":"10","author":"Genant","year":"1999","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.06.003_bb0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-061709-145401","article-title":"New approaches to the treatment of osteoporosis","volume":"62","author":"Silva","year":"2011","journal-title":"Annu. Rev. Med."},{"issue":"11","key":"10.1016\/j.bone.2018.06.003_bb0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrrheum.2011.130","article-title":"New targets for intervention in the treatment of postmenopausal osteoporosis","volume":"7","author":"Lewiecki","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9773","key":"10.1016\/j.bone.2018.06.003_bb0025","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bone.2018.06.003_bb0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11914-017-0353-4","article-title":"Parathyroid hormone and parathyroid hormone-related protein analogs in osteoporosis therapy","volume":"15","author":"Leder","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"issue":"4","key":"10.1016\/j.bone.2018.06.003_bb0035","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jbmr.1784","article-title":"Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT","volume":"28","author":"Hansen","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2018.06.003_bb0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00198-010-1226-1","article-title":"Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis","volume":"22","author":"Macdonald","year":"2011","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bone.2018.06.003_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/cmi.2009.111","article-title":"Regulation of immune cell responses by semaphorins and their receptors","volume":"7","author":"Takamatsu","year":"2010","journal-title":"Cell. Mol. Immunol."},{"issue":"7396","key":"10.1016\/j.bone.2018.06.003_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature11000","article-title":"Osteoprotection by semaphorin 3A","volume":"485","author":"Hayashi","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bone.2018.06.003_bb0055","article-title":"SEMA3A suspended in matrigel improves titanium implant fixation in ovariectomized rats","author":"Li","year":"2016","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.bone.2018.06.003_bb0060","doi-asserted-by":"crossref","first-page":"2545214","DOI":"10.1155\/2016\/2545214","article-title":"Semaphorin 3A shifts adipose mesenchymal stem cells towards osteogenic phenotype and promotes bone regeneration in vivo","volume":"2016","author":"Liu","year":"2016","journal-title":"Stem Cells Int."},{"issue":"6","key":"10.1016\/j.bone.2018.06.003_bb0065","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1021\/mp0600539","article-title":"Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-Hydroxypropyl)methacrylamide copolymers","volume":"3","author":"Wang","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bone.2018.06.003_bb0070","unstructured":"Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-Hydroxypropyl)methacrylamide copolymers. Mol. Pharm."},{"issue":"11","key":"10.1016\/j.bone.2018.06.003_bb0075","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.2489","article-title":"Suppression of bone formation by osteoclastic expression of semaphorin 4D","volume":"17","author":"Negishi-Koga","year":"2011","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bone.2018.06.003_bb0080","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jbmr.2322","article-title":"Anabolic bone formation via a site-specific bone-targeting delivery system by interfering with semaphorin 4D expression","volume":"30","author":"Zhang","year":"2015","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2018.06.003_bb0085","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1177\/0022034514552676","article-title":"Prevention of alveolar bone loss in an osteoporotic animal model via interference of semaphorin 4d","volume":"93","author":"Zhang","year":"2014","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2018.06.003_bb0090","article-title":"Bone scaffolds loaded with siRNA-Semaphorin4d for the treatment of osteoporosis related bone defects","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bone.2018.06.003_bb0095","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1021\/bc7002132","article-title":"Osteotropic peptide that differentiates functional domains of the skeleton","volume":"18","author":"Wang","year":"2007","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.bone.2018.06.003_bb0100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00223-009-9312-0","article-title":"Specific binding and mineralization of calcified surfaces by small peptides","volume":"86","author":"Yarbrough","year":"2010","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.bone.2018.06.003_bb0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm.2617","article-title":"A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"issue":"28","key":"10.1016\/j.bone.2018.06.003_bb0110","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1016\/j.biomaterials.2012.06.021","article-title":"Delivery of PDGF-B and BMP-7 by mesoporous bioglass\/silk fibrin scaffolds for the repair of osteoporotic defects","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.bone.2018.06.003_bb0115","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s10856-013-4945-y","article-title":"Porous CaP\/silk composite scaffolds to repair femur defects in an osteoporotic model","volume":"24","author":"Cheng","year":"2013","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"3","key":"10.1016\/j.bone.2018.06.003_bb0120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11926-010-0097-y","article-title":"The societal burden of osteoporosis","volume":"12","author":"Becker","year":"2010","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"10.1016\/j.bone.2018.06.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006718","article-title":"Semaphorins in angiogenesis and tumor progression","volume":"2","author":"Neufeld","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bone.2018.06.003_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12794","article-title":"GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation","volume":"7","author":"Liu","year":"2016","journal-title":"Nat. Commun."},{"issue":"29","key":"10.1016\/j.bone.2018.06.003_bb0135","doi-asserted-by":"crossref","first-page":"E3893","DOI":"10.1073\/pnas.1501759112","article-title":"PDGFB-based stem cell gene therapy increases bone strength in the mouse","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bone.2018.06.003_bb0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/hum.2016.069","article-title":"Transplantation of adipose tissue-derived mesenchymal stem cell (ATMSC) expressing alpha-1 antitrypsin reduces bone loss in ovariectomized osteoporosis mice","volume":"28","author":"Akbar","year":"2017","journal-title":"Hum. Gene Ther."},{"issue":"9","key":"10.1016\/j.bone.2018.06.003_bb0145","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/hum.2016.029","article-title":"Alpha-1 antitrypsin gene therapy ameliorates bone loss in ovariectomy-induced osteoporosis mouse model","volume":"27","author":"Akbar","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bone.2018.06.003_bb0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bone.2016.10.019","article-title":"Effects of sclerostin antibodies in animal models of osteoporosis","volume":"96","author":"Ominsky","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2018.06.003_bb0155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bone.2017.04.011","article-title":"Effect of the lipoxygenase-inhibitors baicalein and zileuton on the vertebra in ovariectomized rats","volume":"101","author":"Saul","year":"2017","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2018.06.003_bb0160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.addr.2006.03.008","article-title":"Bone tissue engineering by gene delivery","volume":"58","author":"Kofron","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.bone.2018.06.003_bb0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.biomaterials.2006.07.032","article-title":"Virus-based gene therapy strategies for bone regeneration","volume":"28","author":"Phillips","year":"2007","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.bone.2018.06.003_bb0170","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.addr.2006.03.004","article-title":"Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering","volume":"58","author":"Storrie","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.bone.2018.06.003_bb0175","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1177\/0192623317738708","article-title":"Neuronal control of bone remodeling","volume":"45","author":"Corr","year":"2017","journal-title":"Toxicol. Pathol."},{"issue":"6","key":"10.1016\/j.bone.2018.06.003_bb0180","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2826.2008.01732.x","article-title":"Central control of bone remodelling","volume":"20","author":"Takeda","year":"2008","journal-title":"J. Neuroendocrinol."},{"issue":"7450","key":"10.1016\/j.bone.2018.06.003_bb0185","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature12115","article-title":"Sema3A regulates bone-mass accrual through sensory innervations","volume":"497","author":"Fukuda","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bone.2018.06.003_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000455936","article-title":"Diabetes perturbs bone microarchitecture and bone strength through regulation of Sema3A\/IGF-1\/beta-catenin in rats","volume":"41","author":"Ma","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"12","key":"10.1016\/j.bone.2018.06.003_bb0195","doi-asserted-by":"crossref","first-page":"E2504","DOI":"10.1210\/jc.2014-1443","article-title":"Serum Sema3A is in a weak positive association with bone formation marker osteocalcin but not related to bone mineral densities in postmenopausal women","volume":"99","author":"Liu","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5\u20136","key":"10.1016\/j.bone.2018.06.003_bb0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10787-006-0006-1","article-title":"Emerging and future therapies for the treatment of bone loss associated with chronic inflammation","volume":"14","author":"Haynes","year":"2006","journal-title":"Inflammopharmacology"},{"issue":"4","key":"10.1016\/j.bone.2018.06.003_bb0205","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0142-9612(03)00556-8","article-title":"Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NF\u03baB, RANK ligand and osteoprotegerin","volume":"25","author":"Crotti","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2018.06.003_bb0210","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.actbio.2015.11.025","article-title":"Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle induced bone loss","volume":"30","author":"Saad","year":"2016","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.bone.2018.06.003_bb0215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nrendo.2012.252","article-title":"Bone metabolism in 2012: novel osteoporosis targets","volume":"9","author":"Ohlsson","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2018.06.003_bb0220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00223-013-9741-7","article-title":"Osteoclast-derived coupling factors in bone remodeling","volume":"94","author":"Henriksen","year":"2014","journal-title":"Calcif. Tissue Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821830231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821830231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:40:30Z","timestamp":1762659630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632821830231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":44,"alternative-id":["S875632821830231X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2018.06.003","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bone-targeting drug-delivery system based on Semaphorin 3A gene therapy ameliorates bone loss in osteoporotic ovariectomized mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}